Optical genome mapping for structural variation analysis in hematologic malignancies

Optimizing the Diagnostic Workflow for Acute Lymphoblastic Leukemia by Optical Genome Mapping

(2022) Katrina Rack et al.   AMERICAN JOURNAL OF HEMATOLOGY

Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML / MDS patients

(2022) Wanda M. Gerding et al.   INTERNATIONAL JOURNAL OF CANCER

NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022

(2022) Peter L. Greenberg et al.   Journal of the National Comprehensive Cancer Network

A t(6;14;9)(p22;q22;q34) three‐way translocation: Description of a cytogenetically visible variant t(6;9) in acute myeloid leukemia

(2022) Adam C. Smith et al.   AMERICAN JOURNAL OF HEMATOLOGY

NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021

(2021) Daniel A. Pollyea et al.   Journal of the National Comprehensive Cancer Network

Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers

(2021) Eric J. Duncavage et al.   NEW ENGLAND JOURNAL OF MEDICINE

Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias

(2021) Valentin Lestringant et al.   GENES CHROMOSOMES & CANCER

Next-generation cytogenetics: Comprehensive assessment of 52 hematological malignancy genomes by optical genome mapping

(2021) Kornelia Neveling et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Evidence-based review of genomic aberrations in B-lymphoblastic leukemia/lymphoma: Report from the cancer genomics consortium working group for lymphoblastic leukemia

(2020) Yassmine M.N. Akkari et al.   Cancer Genetics

Standardization of Sequencing Coverage Depth in NGS: Recommendation for Detection of Clonal and Subclonal Mutations in Cancer Diagnostics

(2019) Anna Petrackova et al.   Frontiers in Oncology

New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge

(2012) Julie Schanz et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical, Molecular, and Prognostic Significance of WHO Type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and Various Other 3q Abnormalities in Acute Myeloid Leukemia

(2010) Sanne Lugthart et al.   JOURNAL OF CLINICAL ONCOLOGY